Search Results - "Pérez Salvia, Montserrat"
-
1
Bromodomain inhibitors and cancer therapy: From structures to applications
Published in Epigenetics (04-05-2017)“…Aberrations in the epigenetic landscape are a hallmark of cancer. Alterations in enzymes that are "writers," "erasers," or "readers" of histone modification…”
Get full text
Journal Article -
2
In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma
Published in Haematologica (Roma) (01-11-2018)“…Cancer origin and development is associated not only with genetic alterations, but also with the disturbance of epigenetic profiles.1 In this regard, the…”
Get full text
Journal Article -
3
Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer
Published in Oncotarget (01-08-2017)“…BET bromodomain inhibitors, which have an antitumoral effect against various solid cancer tumor types, have not been studied in detail in luminal breast…”
Get full text
Journal Article -
4
Germline variation in O6-methylguanine-DNA methyltransferase (MGMT) as cause of hereditary colorectal cancer
Published in Cancer letters (10-04-2019)“…Somatic epigenetic inactivation of the DNA repair protein O6-methylguanine DNA methyltransferase (MGMT) is frequent in colorectal cancer (CRC); however, its…”
Get full text
Journal Article -
5
Circular RNA CpG island hypermethylation-associated silencing in human cancer
Published in Oncotarget (26-06-2018)“…Noncoding RNAs (ncRNAs), such as microRNAs and long noncoding RNAs (lncRNAs), participate in cellular transformation. Work done in the last decade has also…”
Get full text
Journal Article -
6
KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
Published in Cancer research (Chicago, Ill.) (15-09-2015)“…Recent efforts to sequence human cancer genomes have highlighted that point mutations in genes involved in the epigenetic setting occur in tumor cells. Small…”
Get full text
Journal Article -
7
Barcelona conference on epigenetics and cancer: 50 years of histone acetylation
Published in Epigenetics (04-05-2015)“…The Barcelona Conference on Epigenetics and Cancer (BCEC) was held in Barcelona, Spain, on October 1 st and 2 nd , 2014. The meeting was co-organized by the…”
Get full text
Journal Article Conference Proceeding -
8
Epigenetic loss of the endoplasmic reticulum-associated degradation inhibitor SVIP induces cancer cell metabolic reprogramming
Published in JCI insight (18-04-2019)“…The endoplasmic reticulum (ER) of cancer cells needs to adapt to the enhanced proteotoxic stress associated with the accumulation of unfolded, misfolded and…”
Get full text
Journal Article -
9
Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program
Published in Acta neuropathologica (01-12-2019)“…Tumors have aberrant proteomes that often do not match their corresponding transcriptome profiles. One possible cause of this discrepancy is the existence of…”
Get full text
Journal Article -
10
Abstract 4784: Effect of epigenetic drugs on chromatin remodeling complexes disrupted in cancer
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Chromatin remodeling complexes undergo dynamic assembly of chromatin to facilitate the access to DNA packed in nucleosomes during DNA-template cellular…”
Get full text
Journal Article -
11
Germline variation in O 6 -methylguanine-DNA methyltransferase (MGMT) as cause of hereditary colorectal cancer
Published in Cancer letters (10-04-2019)“…Somatic epigenetic inactivation of the DNA repair protein O6-methylguanine DNA methyltransferase (MGMT) is frequent in colorectal cancer (CRC); however, its…”
Get full text
Journal Article -
12
Barcelona conference on epigenetics and cancer: 50 years of histone acetylation
Published in Epigenetics (05-05-2015)“…The Barcelona Conference on Epigenetics and Cancer (BCEC) was held in Barcelona, Spain, on October 1 and 2 , 2014. The meeting was co-organized by the Cancer…”
Get full text
Journal Article -
13
In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma
Published in Haematologica (Roma) (01-11-2018)“…Cancer origin and development is associated not only with genetic alterations, but also with the disturbance of epigenetic profiles.1 In this regard, the…”
Get full text
Journal Article -
14
Epigenetic loss of RNA‑methyltransferase NSUN5 in glioma targets ribosomes to drive stress adaptive translational program
Published in Acta neuropathologica (13-08-2019)“…Tumors have aberrant proteomes that often do not match their corresponding transcriptome profiles. One possible cause of this discrepancy is the existence of…”
Get full text
Journal Article -
15
Epigenetic loss of RNA‑methyltransferase NSUN5 in glioma targets ribosomes to drive stress adaptive translational program
Published in Acta neuropathologica (13-08-2019)“…Tumors have aberrant proteomes that often do not match their corresponding transcriptome profiles. One possible cause of this discrepancy is the existence of…”
Get full text
Journal Article -
16
Epigenetic loss of RNA‑methyltransferase NSUN5 in glioma targets ribosomes to drive stress adaptive translational program
Published in Acta neuropathologica (13-08-2019)“…Tumors have aberrant proteomes that often do not match their corresponding transcriptome profiles. One possible cause of this discrepancy is the existence of…”
Get full text
Journal Article -
17
Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer
Published in Oncotarget (29-05-2017)“…BET bromodomain inhibitors, which have an antitumoral effect against various solid cancer tumor types, have not been studied in detail in luminal breast…”
Get full text
Journal Article -
18
Abstract 4725: Efficacy of a new small-molecule inhibitor of histone deacetylase 6 (HDAC6) in preclinical models of B-cell lymphoma and acute myeloid leukemia
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Histone deacetylase 6 (HDAC6) is a protein modifier that is an increasingly attractive pharmacological target. Interestingly, the observation that the HDAC6…”
Get full text
Journal Article -
19
Efficacy of a New Small-Molecule Inhibitor of Histone Deacetylase 6 (HDAC6) in Preclinical Models of B-Cell Lymphoma and Acute Myeloid Leukemia
Published in Blood (29-11-2018)“…Histone deacetylase 6 (HDAC6) is a protein modifier that is an increasingly attractive pharmacological target. Interestingly, the observation that the HDAC6…”
Get full text
Journal Article